Your browser doesn't support javascript.
loading
Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments.
Zhou, Bin; Achanta, Prabhakar S; Shetye, Gauri; Chen, Shao-Nong; Lee, Hyun; Jin, Ying-Yu; Cheng, Jinhua; Lee, Mi-Jin; Suh, Joo-Won; Cho, Sanghyun; Franzblau, Scott G; Pauli, Guido F; McAlpine, James B.
Afiliación
  • Zhou B; Institute for Tuberculosis Research, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Achanta PS; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Shetye G; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Chen SN; Pharmacognosy Institute, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Lee H; Institute for Tuberculosis Research, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Jin YY; Institute for Tuberculosis Research, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Cheng J; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Lee MJ; Pharmacognosy Institute, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Suh JW; Institute for Tuberculosis Research, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Cho S; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Franzblau SG; Biophysics Core at Research Resources Center, University of Illinois at Chicago, Chicago, Illinois 60607, United States.
  • Pauli GF; Man Bang Bio Co., Ltd., Subsidiary of Myongji University Technology Holdings Ltd., Cheoin-gu, Yongin-si, Gyeonggi-do 17058, Republic of Korea.
  • McAlpine JB; Myongji Bioefficacy Research Center, Myongji University, Cheoin-gu, Yongin-si, Gyeonggi-do 17058, Republic of Korea.
J Nat Prod ; 84(10): 2644-2663, 2021 10 22.
Article en En | MEDLINE | ID: mdl-34628863
Rufomycin and ilamycin are synonymous for the same class of cyclopeptides, currently encompassing 33 structurally characterized isolates and 9 semisynthetic derivatives. Elucidation of new structures prioritized the consolidation of the names and established the structures of four diastereoisomeric rufomycins with a 2-piperidinone, named rufomycins 4-7, including full 1H/13C NMR assignments. The characteristic HSQC cross-peak for the CH-5, the hemiaminal carbon in amino acid #5, allows assignment of the stereocenters C-4 and C-5 within this ring. Semisynthetic derivatives (rufomycinSS 1, 2, and 3) were prepared from a rufomycins 4 and 6 mixture to validate the structural assignments. Based on the X-ray crystal structures of rufomycins 2 and 4, considering the NMR differences of rufomycins 7 vs 4-6 compared to rufomycinSS 1 vs 2 and 3, and taking into account that two major conformers, A and B, occur in both rufomycinSS 2 and 3, structural modeling was pursued. Collectively, this paper discusses the NMR spectroscopic differences of the stereoisomers and their possible 3D conformers and correlates these with the anti-Mycobacterium tuberculosis activity. In addition, a look at the history prioritizes names and numbering schemes for this group of antibiotics and leads to consolidated nomenclature for all currently known members, natural and semisynthetic derivatives, and serves to accommodate future discoveries.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Péptidos Cíclicos Tipo de estudio: Prognostic_studies Idioma: En Revista: J Nat Prod Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Péptidos Cíclicos Tipo de estudio: Prognostic_studies Idioma: En Revista: J Nat Prod Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos